Immunome
IMNM
15.69
-0.92
-5.54%
Immunome
US · IMNM
#2671 by market cap
Listed 2020
15.69
-0.92
-5.54%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
J.P. Morgan Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $39Market Newswire · 2026/6/12
-
Rating change
Craig-Hallum Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $36Market Newswire · 2026/6/11
-
Rating change
Analysts Offer Insights on Healthcare Companies: Evommune, Inc. (EVMN), Immunome (IMNM) and Alcon (ALC)TipRanks · 2026/6/12
-
Rating change
Piper Sandler Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $33Market Newswire · 2026/6/1
-
Rating change
Lake Street Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $30Market Newswire · 2026/6/1
-
LifeSci Capital Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/10/6
-
H.C. Wainwright Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/11/5
-
A Quick Look at Today's Ratings for Immunome(IMNM.US), With a Forecast Between $23 to $40Market Newswire · 2026/11/11
-
Rating change
Truist Financial Maintains Immunome(IMNM.US) With Buy RatingMarket Newswire · 2026/7/9
-
Rating change
A Quick Look at Today's Ratings for Immunome(IMNM.US), With a Forecast Between $33 to $40Market Newswire · 2026/8/13
-
Barclays Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $36Market Newswire · 2026/10/27
-
Rating change
J.P. Morgan Maintains Immunome(IMNM.US) With Buy RatingMarket Newswire · 2026/6/30
-
Rating change
Stifel Initiates Immunome(IMNM.US) With Hold Rating, Announces Target Price $24Market Newswire · 2026/10/1
-
Rating change
A. G. P. Initiates Immunome(IMNM.US) With Buy Rating, Announces Target Price $32Market Newswire · 2026/9/21
-
William Blair Initiates Immunome(IMNM.US) With Buy Rating, Announces Target Price $35Market Newswire · 2026/10/16
-
Rating change
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Maze Therapeutics, Inc. (MAZE) and Immunome (IMNM)TipRanks · 2026/8/12
-
Rating change
Analysts Offer Insights on Healthcare Companies: Fortrea Holdings Inc. (FTRE) and Immunome (IMNM)TipRanks · 2026/9/10
-
Rating change
Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Immunome (IMNM) and Incyte (INCY)TipRanks · 2026/7/22
-
Rating change
Stifel Maintains Immunome(IMNM.US) With Hold Rating, Maintains Target Price $24Market Newswire · 2026/10/6
-
Rating change
Analysts Offer Insights on Healthcare Companies: Kailera Therapeutics, Inc. (KLRA) and Immunome (IMNM)TipRanks · 2026/9/30
-
H.C. Wainwright Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/10/31
-
Rating change
Truist Financial Initiates Immunome(IMNM.US) With Buy Rating, Announces Target Price $37Market Newswire · 2026/5/28
-
Rating change
H.C. Wainwright Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $40Market Newswire · 2026/9/11
-
Barclays Maintains Immunome(IMNM.US) With Buy Rating, Maintains Target Price $36Market Newswire · 2026/10/1
-
Rating change
Leerink Partners Maintains Immunome(IMNM.US) With Buy Rating, Cuts Target Price to $33Market Newswire · 2026/5/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.
Immunome discussion 0 comments